NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/28/2024
Back to search
Official data from USPTO
DALLAS FIBROID CENTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
DALLAS FIBROID CENTER
ST13
US500000097877814Class
44
Filing
97877814
Registration
7403796
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
05/28/2024
Classification
Registered
Trademark type
Word
Nice classes
44
Filing date
04/07/2023
Registration date
05/28/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/28/2024
Last transaction
05/28/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
06/23/2023
First use in commerce
06/23/2023
Drawing code
4
Owner type
16
Owner location
BELLAIRE, TX
Examiner
SPARACINO, MARK
Law office
L30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Texas Endovascular Associates, PLLC
Representatives
Winston Huff MUNSCH HARDT KOPFT & HARR
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical servicestreatment of adenomyosis and leiomyoma
Publications
History of USPTO decisions and trademark events.
15 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/28/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
04/23/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
04/22/2024
IUAA
USE AMENDMENT ACCEPTED
04/22/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/02/2024
IUAF
USE AMENDMENT FILED
04/02/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
04/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/11/2024
GNRT
NON-FINAL ACTION E-MAILED
01/11/2024
CNRT
NON-FINAL ACTION WRITTEN
01/11/2024
DOCK
ASSIGNED TO EXAMINER
01/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/02/2023
NWAP
NEW APPLICATION ENTERED
04/11/2023
Continuous trademark protection
Get notified about every new filing that threatens DALLAS FIBROID CENTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.